DK0430491T3 - Transdermalt afgivelsesorgan for estradiol og fremgangsmåde til fremstilling af organet - Google Patents

Transdermalt afgivelsesorgan for estradiol og fremgangsmåde til fremstilling af organet

Info

Publication number
DK0430491T3
DK0430491T3 DK90312435.2T DK90312435T DK0430491T3 DK 0430491 T3 DK0430491 T3 DK 0430491T3 DK 90312435 T DK90312435 T DK 90312435T DK 0430491 T3 DK0430491 T3 DK 0430491T3
Authority
DK
Denmark
Prior art keywords
organ
producing
delivery means
transdermal estradiol
estradiol delivery
Prior art date
Application number
DK90312435.2T
Other languages
English (en)
Other versions
DK0430491T4 (da
Inventor
Francisco Jose Evarist Stefano
Jose Adrian Nowogrodski
Dario Norberto Ramon Carrara
Original Assignee
Beta Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3478739&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0430491(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beta Pharm Co filed Critical Beta Pharm Co
Publication of DK0430491T3 publication Critical patent/DK0430491T3/da
Application granted granted Critical
Publication of DK0430491T4 publication Critical patent/DK0430491T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK90312435T 1989-11-17 1990-11-14 Transdermalt afgivelsesorgan for estradiol og fremgangsmåde til fremstilling af organet DK0430491T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AR89315479A AR246186A1 (es) 1989-11-17 1989-11-17 Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.

Publications (2)

Publication Number Publication Date
DK0430491T3 true DK0430491T3 (da) 1994-09-19
DK0430491T4 DK0430491T4 (da) 2001-01-02

Family

ID=3478739

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90312435T DK0430491T4 (da) 1989-11-17 1990-11-14 Transdermalt afgivelsesorgan for estradiol og fremgangsmåde til fremstilling af organet

Country Status (9)

Country Link
EP (1) EP0430491B2 (da)
JP (1) JPH03227920A (da)
AR (1) AR246186A1 (da)
AT (1) ATE106753T1 (da)
BR (1) BR9005908A (da)
DE (1) DE69009697T3 (da)
DK (1) DK0430491T4 (da)
ES (1) ES2057442T5 (da)
MX (1) MX171907B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4210165A1 (de) * 1991-07-30 1993-02-04 Schering Ag Transdermale therapeutische systeme
JP2960832B2 (ja) * 1992-05-08 1999-10-12 ペルマテック テクノロジー アクチェンゲゼルシャフト エストラジオールの投与システム
DE4237453C1 (da) * 1992-11-06 1993-08-19 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4400770C1 (de) * 1994-01-13 1995-02-02 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster zur Abgabe von Estradiol mit mindestens einem Penetrationsverstärker, Verfahren zu seiner Herstellung und seine Verwendung
GR1002079B (en) * 1994-07-26 1995-12-05 Lavipharm A E System of a special structure and composition for the rapid transdermal administration of oestrogens.
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
GB9720470D0 (en) 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
US5968919A (en) * 1997-10-16 1999-10-19 Macrochem Corporation Hormone replacement therapy drug formulations for topical application to the skin
DE19815060A1 (de) * 1998-04-03 1999-10-14 Jenapharm Gmbh Pharmazeutische Präparate zur Therapie von Nebenwirkungen während und/oder nach einer GnRHa-Therapie
SE9801704D0 (sv) 1998-05-14 1998-05-14 Bioglan Ab Biologically active composition
DE10003397A1 (de) * 2000-01-27 2001-08-09 Hartmann Paul Ag Polyelektrolyt-Feststoffsystem, Verfahren zur Herstellung desselben sowie Wundverband
DE10019171A1 (de) * 2000-04-07 2001-10-18 Schering Ag Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4764381A (en) * 1985-12-06 1988-08-16 Key Pharmaceuticals, Inc. Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, 3-hexanediol
US4908389A (en) * 1986-08-27 1990-03-13 Warner-Lambert Company Penetration enhancement system
US4994267A (en) † 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
WO1990006120A1 (en) * 1988-12-01 1990-06-14 Schering Corporation Compositions for transdermal delivery of estradiol

Also Published As

Publication number Publication date
MX171907B (es) 1993-11-23
DE69009697D1 (de) 1994-07-14
EP0430491B2 (en) 2000-10-25
ES2057442T3 (es) 1994-10-16
JPH03227920A (ja) 1991-10-08
ATE106753T1 (de) 1994-06-15
DE69009697T2 (de) 1994-12-22
AR246186A1 (es) 1994-07-29
DE69009697T3 (de) 2001-02-22
EP0430491A2 (en) 1991-06-05
ES2057442T5 (es) 2001-02-16
BR9005908A (pt) 1991-09-24
DK0430491T4 (da) 2001-01-02
EP0430491A3 (en) 1991-12-27
EP0430491B1 (en) 1994-06-08

Similar Documents

Publication Publication Date Title
DK148388D0 (da) Blandeapparat og fremgangsmaade til fremstilling af dette
DK55287A (da) Neuritaktiverende faktor og fremgangsmaade til fremstilling deraf
DK4191D0 (da) Polymersammensaetning og fremgangsmaade til fremstilling af denne
DK6990D0 (da) Manupuleringsafsloerende lukke og fremgangsmaade til fremstilling af dette
DK378388A (da) Fremgangsmaade og apparat til fremstilling af pyramidestubformede daaseemner
DK0430491T3 (da) Transdermalt afgivelsesorgan for estradiol og fremgangsmåde til fremstilling af organet
DK491087A (da) Tumor-egress-faktor (egressin) og fremgangsmaade til fremstilling heraf
DK554485D0 (da) Geltandplejemiddel og fremgangsmaade til fremstilling deraf
DK159288D0 (da) Saccharidblanding og fremgangsmaade til fremstilling deraf
DK0384323T3 (da) Sammensætning og fremgangsmåde til forstærkning af en fiskevaccines virkning
DK355387A (da) Overtraekspraeparat og fremgangsmaade til anvendelse deraf
DK241790D0 (da) Fremgangsmaade til fremstilling af sucralfat og aai-10001
DK0416216T3 (da) Fremgangsmåde og form til fremstilling af beklædte paneler/plader
NO924300L (no) Fremgangsmaate og anordning til fremstilling av vibrerte betongelementer
DK229888D0 (da) Fremgangsmaade og indretning til udlaegning af plastroer
DK0425001T3 (da) Naturlige delta-lactoner og fremgangsmåde til fremstilling deraf
DK266390D0 (da) Injicerbar oploesning og fremgangsmaade til fremstilling deraf
DK39689D0 (da) Fremgangsmaade til fremstilling af n-phosphonmethyliminodieddikesyre og n-phosphonmethyliminodieddikesyrechlorid
DK221689A (da) Naturstensplade og fremgangsmaade til fremstilling af naturstensplade
DK585988A (da) Isopolypeptider og fremgangsmaade til fremstilling deraf
DK0388620T3 (da) Fremgangsmåde til fremstilling af o-carboxy-pyridyl- og o-carboxyquinolylimidazolinoner
NO921168L (no) Fremgangsmaate og anordning for fremstilling av elementaertjod i ren form
DK129689D0 (da) Ifosfamid-mesna-lyofilisat og fremgangsmaade til fremstilling deraf
NO890738L (no) Fremgangsmaate og anordning for kontinuerlig stoeping av betongkonstruksjoner.
DK680488D0 (da) Lerdue og fremgangsmaade til fremstilling af samme